Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Rheumatic manifestations of chikungunya: emerging concepts and interventions.

Suhrbier A.

Nat Rev Rheumatol. 2019 Oct;15(10):597-611. doi: 10.1038/s41584-019-0276-9. Epub 2019 Sep 3. Review.

PMID:
31481759
2.

Interpreting paired serology for Ross River virus and Barmah Forest virus diseases.

Farmer JF, Suhrbier A.

Aust J Gen Pract. 2019 Sep;48(9):645-649. doi: 10.31128/AJGP-02-19-4845.

3.

SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages.

Schroder WA, Hirata TD, Le TT, Gardner J, Boyle GM, Ellis J, Nakayama E, Pathirana D, Nakaya HI, Suhrbier A.

Sci Rep. 2019 Aug 27;9(1):12421. doi: 10.1038/s41598-019-48741-w.

4.

Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.

de Lima DS, Cardozo LE, Maracaja-Coutinho V, Suhrbier A, Mane K, Jeffries D, Silveira ELV, Amaral PP, Rappuoli R, de Silva TI, Nakaya HI.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):17121-17126. doi: 10.1073/pnas.1822046116. Epub 2019 Aug 9.

5.

Systems analysis of subjects acutely infected with the Chikungunya virus.

Soares-Schanoski A, Baptista Cruz N, de Castro-Jorge LA, de Carvalho RVH, Santos CAD, Rós ND, Oliveira Ú, Costa DD, Santos CLSD, Cunha MDP, Oliveira MLS, Alves JC, Océa RALC, Ribeiro DR, Gonçalves ANA, Gonzalez-Dias P, Suhrbier A, Zanotto PMA, Azevedo IJ, Zamboni DS, Almeida RP, Ho PL, Kalil J, Nishiyama MY Junior, Nakaya HI.

PLoS Pathog. 2019 Jun 18;15(6):e1007880. doi: 10.1371/journal.ppat.1007880. eCollection 2019 Jun.

6.

Determinants of Zika virus host tropism uncovered by deep mutational scanning.

Setoh YX, Amarilla AA, Peng NYG, Griffiths RE, Carrera J, Freney ME, Nakayama E, Ogawa S, Watterson D, Modhiran N, Nanyonga FE, Torres FJ, Slonchak A, Periasamy P, Prow NA, Tang B, Harrison J, Hobson-Peters J, Cuddihy T, Cooper-White J, Hall RA, Young PR, Mackenzie JM, Wolvetang E, Bloom JD, Suhrbier A, Khromykh AA.

Nat Microbiol. 2019 May;4(5):876-887. doi: 10.1038/s41564-019-0399-4. Epub 2019 Mar 18.

PMID:
30886357
7.

Inhibition of Interleukin-1β Signaling by Anakinra Demonstrates a Critical Role of Bone Loss in Experimental Arthritogenic Alphavirus Infections.

Wolf S, Taylor A, Zaid A, Freitas J, Herrero LJ, Rao S, Suhrbier A, Forwood MR, Bucala R, Mahalingam S.

Arthritis Rheumatol. 2019 Jul;71(7):1185-1190. doi: 10.1002/art.40856. Epub 2019 Jun 6.

PMID:
30747500
8.

SerpinB2 deficiency in mice reduces bleeding times via dysregulated platelet activation.

Schroder WA, Le TT, Gardner J, Andrews RK, Gardiner EE, Callaway L, Suhrbier A.

Platelets. 2019;30(5):658-663. doi: 10.1080/09537104.2018.1535702. Epub 2018 Nov 2.

PMID:
30388956
9.

Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines.

Prow NA, Jimenez Martinez R, Hayball JD, Howley PM, Suhrbier A.

Expert Rev Vaccines. 2018 Oct;17(10):925-934. doi: 10.1080/14760584.2018.1522255. Epub 2018 Oct 9. Review.

PMID:
30300041
10.

Fetal Brain Infection Is Not a Unique Characteristic of Brazilian Zika Viruses.

Setoh YX, Peng NY, Nakayama E, Amarilla AA, Prow NA, Suhrbier A, Khromykh AA.

Viruses. 2018 Oct 3;10(10). pii: E541. doi: 10.3390/v10100541.

11.

Ilheus and Saint Louis encephalitis viruses elicit cross-protection against a lethal Rocio virus challenge in mice.

Amarilla AA, Fumagalli MJ, Figueiredo ML, Lima-Junior DS, Santos-Junior NN, Alfonso HL, Lippi V, Trabuco AC, Lauretti F, Muller VD, Colón DF, Luiz JPM, Suhrbier A, Setoh YX, Khromykh AA, Figueiredo LTM, Aquino VH.

PLoS One. 2018 Jun 13;13(6):e0199071. doi: 10.1371/journal.pone.0199071. eCollection 2018.

12.

A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.

Prow NA, Liu L, Nakayama E, Cooper TH, Yan K, Eldi P, Hazlewood JE, Tang B, Le TT, Setoh YX, Khromykh AA, Hobson-Peters J, Diener KR, Howley PM, Hayball JD, Suhrbier A.

Nat Commun. 2018 Mar 26;9(1):1230. doi: 10.1038/s41467-018-03662-6.

13.

Mapping the virome in wild-caught Aedes aegypti from Cairns and Bangkok.

Zakrzewski M, Rašić G, Darbro J, Krause L, Poo YS, Filipović I, Parry R, Asgari S, Devine G, Suhrbier A.

Sci Rep. 2018 Mar 16;8(1):4690. doi: 10.1038/s41598-018-22945-y.

14.

New genotypes of Liao ning virus (LNV) in Australia exhibit an insect-specific phenotype.

Prow NA, Mah MG, Deerain JM, Warrilow D, Colmant AMG, O'Brien CA, Harrison JJ, McLean BJ, Hewlett EK, Piyasena TBH, Hall-Mendelin S, van den Hurk AF, Watterson D, Huang B, Schulz BL, Webb CE, Johansen CA, Chow WK, Hobson-Peters J, Cazier C, Coffey LL, Faddy HM, Suhrbier A, Bielefeldt-Ohmann H, Hall RA.

J Gen Virol. 2018 Apr;99(4):596-609. doi: 10.1099/jgv.0.001038. Epub 2018 Mar 13.

PMID:
29533743
15.

IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage Plasmodium Infection.

James KR, Soon MSF, Sebina I, Fernandez-Ruiz D, Davey G, Liligeto UN, Nair AS, Fogg LG, Edwards CL, Best SE, Lansink LIM, Schroder K, Wilson JAC, Austin R, Suhrbier A, Lane SW, Hill GR, Engwerda CR, Heath WR, Haque A.

J Immunol. 2018 Feb 15;200(4):1443-1456. doi: 10.4049/jimmunol.1700782. Epub 2018 Jan 10.

16.

Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.

Prow NA, Tang B, Gardner J, Le TT, Taylor A, Poo YS, Nakayama E, Hirata TDC, Nakaya HI, Slonchak A, Mukhopadhyay P, Mahalingam S, Schroder WA, Klimstra W, Suhrbier A.

PLoS Pathog. 2017 Dec 27;13(12):e1006788. doi: 10.1371/journal.ppat.1006788. eCollection 2017 Dec.

17.

Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation.

Chen W, Foo SS, Zaid A, Teng TS, Herrero LJ, Wolf S, Tharmarajah K, Vu LD, van Vreden C, Taylor A, Freitas JR, Li RW, Woodruff TM, Gordon R, Ojcius DM, Nakaya HI, Kanneganti TD, O'Neill LAJ, Robertson AAB, King NJ, Suhrbier A, Cooper MA, Ng LFP, Mahalingam S.

Nat Microbiol. 2017 Oct;2(10):1435-1445. doi: 10.1038/s41564-017-0015-4. Epub 2017 Aug 28.

PMID:
28848230
18.

Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.

Eldi P, Cooper TH, Liu L, Prow NA, Diener KR, Howley PM, Suhrbier A, Hayball JD.

Mol Ther. 2017 Oct 4;25(10):2332-2344. doi: 10.1016/j.ymthe.2017.06.017. Epub 2017 Jul 15.

19.

Tattoo removal with ingenol mebutate.

Cozzi SJ, Le TT, Ogbourne SM, James C, Suhrbier A.

Clin Cosmet Investig Dermatol. 2017 May 25;10:205-210. doi: 10.2147/CCID.S135716. eCollection 2017.

20.

De Novo Generation and Characterization of New Zika Virus Isolate Using Sequence Data from a Microcephaly Case.

Setoh YX, Prow NA, Peng N, Hugo LE, Devine G, Hazlewood JE, Suhrbier A, Khromykh AA.

mSphere. 2017 May 17;2(3). pii: e00190-17. doi: 10.1128/mSphereDirect.00190-17. eCollection 2017 May-Jun.

21.

RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Wilson JA, Prow NA, Schroder WA, Ellis JJ, Cumming HE, Gearing LJ, Poo YS, Taylor A, Hertzog PJ, Di Giallonardo F, Hueston L, Le Grand R, Tang B, Le TT, Gardner J, Mahalingam S, Roques P, Bird PI, Suhrbier A.

PLoS Pathog. 2017 Feb 16;13(2):e1006155. doi: 10.1371/journal.ppat.1006155. eCollection 2017 Feb.

22.

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

Pyankov OV, Setoh YX, Bodnev SA, Edmonds JH, Pyankova OG, Pyankov SA, Pali G, Belford S, Lu L, La M, Lovrecz G, Volchkova VA, Chappell KJ, Watterson D, Marsh G, Young PR, Agafonov AA, Farmer JF, Volchkov VE, Suhrbier A, Khromykh AA.

Sci Rep. 2017 Feb 3;7:41537. doi: 10.1038/srep41537.

23.

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.

Tomusange K, Wijesundara D, Gummow J, Wesselingh S, Suhrbier A, Gowans EJ, Grubor-Bauk B.

Sci Rep. 2016 Nov 17;6:36658. doi: 10.1038/srep36658.

24.

Chikungunya virus transmission between Aedes albopictus and laboratory mice.

Hugo LE, Prow NA, Tang B, Devine G, Suhrbier A.

Parasit Vectors. 2016 Oct 19;9(1):555.

25.

SerpinB2 Deficiency Results in a Stratum Corneum Defect and Increased Sensitivity to Topically Applied Inflammatory Agents.

Schroder WA, Anraku I, Le TT, Hirata TD, Nakaya HI, Major L, Ellis JJ, Suhrbier A.

Am J Pathol. 2016 Jun;186(6):1511-23. doi: 10.1016/j.ajpath.2016.02.017. Epub 2016 Apr 22.

PMID:
27109612
26.

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.

Le TT, Skak K, Schroder K, Schroder WA, Boyle GM, Pierce CJ, Suhrbier A.

PLoS One. 2016 Apr 21;11(4):e0153975. doi: 10.1371/journal.pone.0153975. eCollection 2016.

27.

Chikungunya virus, risks and responses for Australia.

Suhrbier A, Devine G.

Aust N Z J Public Health. 2016 Jun;40(3):207-9. doi: 10.1111/1753-6405.12515. Epub 2016 Mar 30. Review. No abstract available.

PMID:
27028514
28.

Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans.

Gardner J, Rudd PA, Prow NA, Belarbi E, Roques P, Larcher T, Gresh L, Balmaseda A, Harris E, Schroder WA, Suhrbier A.

PLoS One. 2015 Oct 8;10(10):e0139481. doi: 10.1371/journal.pone.0139481. eCollection 2015.

29.

Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm.

Rudd PA, Raphael AP, Yamada M, Nufer KL, Gardner J, Le TT, Prow NA, Dang N, Schroder WA, Prow TW, Suhrbier A.

Vaccine. 2015 Sep 22;33(39):5172-80. doi: 10.1016/j.vaccine.2015.07.099. Epub 2015 Aug 18.

PMID:
26296498
30.

SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation.

Lee JA, Yerbury JJ, Farrawell N, Shearer RF, Constantinescu P, Hatters DM, Schroder WA, Suhrbier A, Wilson MR, Saunders DN, Ranson M.

PLoS One. 2015 Jun 17;10(6):e0130136. doi: 10.1371/journal.pone.0130136. eCollection 2015.

31.

Engineering human rhinovirus serotype-A1 as a vaccine vector.

Tomusange K, Yu W, Suhrbier A, Wijesundara D, Grubor-Bauk B, Gowans EJ.

Virus Res. 2015 May 4;203:72-6. doi: 10.1016/j.virusres.2015.04.002. Epub 2015 Apr 11.

PMID:
25869880
32.

A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.

Pyankov OV, Bodnev SA, Pyankova OG, Solodkyi VV, Pyankov SA, Setoh YX, Volchkova VA, Suhrbier A, Volchkov VV, Agafonov AA, Khromykh AA.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S368-71. doi: 10.1093/infdis/jiv019. Epub 2015 Mar 2.

33.

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.

Gargett T, Grubor-Bauk B, Miller D, Garrod T, Yu S, Wesselingh S, Suhrbier A, Gowans EJ.

Clin Transl Immunology. 2014 Jun 27;3(6):e18. doi: 10.1038/cti.2014.13. eCollection 2014 Jun.

34.

Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications.

Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Suhrbier A, Hall RA.

J Gen Virol. 2015 Mar;96(Pt 3):507-12. doi: 10.1099/jgv.0.000002. Epub 2014 Dec 5.

PMID:
25480927
35.

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection.

Poo YS, Rudd PA, Gardner J, Wilson JA, Larcher T, Colle MA, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3354. doi: 10.1371/journal.pntd.0003354. eCollection 2014 Dec.

36.

Chikungunya virus non-structural protein 2-mediated host shut-off disables the unfolded protein response.

Fros JJ, Major LD, Scholte FEM, Gardner J, van Hemert MJ, Suhrbier A, Pijlman GP.

J Gen Virol. 2015 Mar;96(Pt 3):580-589. doi: 10.1099/vir.0.071845-0. Epub 2014 Nov 13.

PMID:
25395592
37.

Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag.

Garrod TJ, Gargett T, Yu W, Major L, Burrell CJ, Wesselingh S, Suhrbier A, Grubor-Bauk B, Gowans EJ.

Virus Res. 2014 Nov 4;192:25-33. doi: 10.1016/j.virusres.2014.08.008. Epub 2014 Aug 23.

PMID:
25152448
38.

IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice.

Spann KM, Loh Z, Lynch JP, Ullah A, Zhang V, Baturcam E, Werder RB, Khajornjiraphan N, Rudd P, Loo YM, Suhrbier A, Gale M Jr, Upham JW, Phipps S.

Am J Pathol. 2014 Jun;184(6):1795-806. doi: 10.1016/j.ajpath.2014.02.026. Epub 2014 Apr 13.

PMID:
24726644
39.

DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency.

Garrod TJ, Grubor-Bauk B, Gargett T, Li Y, Miller DS, Yu W, Major L, Burrell CJ, Wesselingh S, Suhrbier A, Gowans EJ.

Eur J Immunol. 2014 Jul;44(7):1992-2002. doi: 10.1002/eji.201343983. Epub 2014 May 11.

40.

CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis.

Poo YS, Nakaya H, Gardner J, Larcher T, Schroder WA, Le TT, Major LD, Suhrbier A.

J Virol. 2014 Jun;88(12):6862-72. doi: 10.1128/JVI.03364-13. Epub 2014 Apr 2.

41.

Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis.

Schroder WA, Major LD, Le TT, Gardner J, Sweet MJ, Janciauskiene S, Suhrbier A.

Cancer Med. 2014 Jun;3(3):500-13. doi: 10.1002/cam4.229. Epub 2014 Mar 19.

42.

Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response.

Gargett T, Grubor-Bauk B, Garrod TJ, Yu W, Miller D, Major L, Wesselingh S, Suhrbier A, Gowans EJ.

Immunol Cell Biol. 2014 Apr;92(4):359-67. doi: 10.1038/icb.2013.93. Epub 2013 Dec 10.

PMID:
24323081
43.

Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model.

Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Pyke AT, Suhrbier A, Hall RA.

Clin Immunol. 2013 Dec;149(3):487-97. doi: 10.1016/j.clim.2013.10.004. Epub 2013 Oct 12.

PMID:
24239837
44.

Are Impact Factors corrupting truth and utility in biomedical research?

Suhrbier A, Poland GA.

Vaccine. 2013 Dec 9;31(51):6041-2. doi: 10.1016/j.vaccine.2013.09.076. Epub 2013 Oct 31. No abstract available.

PMID:
24184289
45.

A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.

Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, Barnes T, Mabila M, Zhou X, Rossini G, Rucker JB, Sanders DA, Suhrbier A, Sambri V, Michault A, Muench MO, Doranz BJ, Simmons G.

PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423. doi: 10.1371/journal.pntd.0002423. eCollection 2013.

46.

Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.

Ziemssen T, Kempcke R, Eulitz M, Großmann L, Suhrbier A, Thomas K, Schultheiss T.

J Neural Transm (Vienna). 2013 Sep;120 Suppl 1:S61-6. doi: 10.1007/s00702-013-1041-x. Epub 2013 Jun 1. Review.

PMID:
23728704
47.

Effective chikungunya virus-like particle vaccine produced in insect cells.

Metz SW, Gardner J, Geertsema C, Le TT, Goh L, Vlak JM, Suhrbier A, Pijlman GP.

PLoS Negl Trop Dis. 2013;7(3):e2124. doi: 10.1371/journal.pntd.0002124. Epub 2013 Mar 14.

48.

Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivo.

Major LD, Partridge TS, Gardner J, Kent SJ, de Rose R, Suhrbier A, Schroder WA.

PLoS One. 2013;8(2):e57343. doi: 10.1371/journal.pone.0057343. Epub 2013 Feb 27.

49.

Circulating heat shock protein 60 levels are elevated in HIV patients and are reduced by anti-retroviral therapy.

Anraku I, Rajasuriar R, Dobbin C, Brown R, Lewin SR, Suhrbier A.

PLoS One. 2012;7(9):e45291. doi: 10.1371/journal.pone.0045291. Epub 2012 Sep 28.

50.

Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice.

Cozzi SJ, Le TT, Ogbourne SM, James C, Suhrbier A.

Arch Dermatol Res. 2013 Jan;305(1):79-83. doi: 10.1007/s00403-012-1270-0. Epub 2012 Aug 8.

Supplemental Content

Loading ...
Support Center